Philips announces Q3 2020 results and provides new financial targets for the 2021–2025 period

Nachrichtenquelle: globenewswire
19.10.2020, 07:00  |  179   |   |   


October 19, 2020

Philips delivers Q3 sales of EUR 5.0 billion, with 10% comparable sales growth; income from continuing operations increases to EUR 341 million, Adjusted EBITA margin improves 300 basis points to 15.4%, and operating cash flow increases to EUR 770 million

Philips provides new financial targets for the 2021–2025 period

Third-quarter highlights
•        Sales amounted to EUR 5.0 billion, with 10% comparable sales growth
•        Comparable order intake increased 3% excluding the partial termination of the ventilator contract with HHS*); reported comparable order intake declined 18%
•        Income from continuing operations increased to EUR 341 million, compared to EUR 211 million in Q3 2019
•        Adjusted EBITA margin increased to 15.4% of sales, compared to 12.4% of sales in Q3 2019
•        Income from operations improved to EUR 476 million, compared to EUR 320 million in Q3 2019
•        EPS from continuing operations (diluted) amounted to EUR 0.37; Adjusted EPS increased to EUR 0.60, compared to EUR 0.46 in Q3 2019
•        Operating cash flow improved to EUR 770 million, compared to EUR 356 million in Q3 2019


Frans van Houten, CEO
 “It is clear that the COVID-19 pandemic is far from over, and our teams remain fully focused on delivering against our triple duty of care: meeting critical customer needs, safeguarding the health and safety of our employees, and ensuring business continuity.

I am pleased that, under challenging circumstances, we have been able to execute our plans and return to growth and improved profitability for the Group in the third quarter. Driven by the successful conversion of the Connected Care order book for patient monitors and ventilators, and a robust rebound of demand for our Personal Health portfolio, Philips recorded a strong 10% comparable sales growth and delivered an Adjusted EBITA margin improvement of 300 basis points to 15.4%.

The Connected Care businesses delivered a very strong 42% comparable sales growth, and our Personal Health businesses delivered a healthy 6% comparable sales growth. I am encouraged by the performance improvement of our Diagnosis & Treatment businesses to a low-single-digit comparable sales decline from a high-single-digit decline in the previous quarter.

Seite 1 von 9
Koninklijke Philips Aktie jetzt über den Testsieger (Finanztest 11/2020) handeln, ab 0 € auf Smartbroker.de



Diesen Artikel teilen

0 Kommentare

Schreibe Deinen Kommentar

Bitte melden Sie sich an, um zu kommentieren. Anmelden | Registrieren

 

Disclaimer

Philips announces Q3 2020 results and provides new financial targets for the 2021–2025 period October 19, 2020 Philips delivers Q3 sales of EUR 5.0 billion, with 10% comparable sales growth; income from continuing operations increases to EUR 341 million, Adjusted EBITA margin improves 300 basis points to 15.4%, and operating cash flow …

Meistgelesene Nachrichten des Autors

Titel
Titel
Titel
Titel